persons/year and can cause blindness. Its management requires antifungals to penetrate
the ocular tissue. Oral use of Ketoconazole (KTZ), the first broad-spectrum antifungal to be
marketed, is now restricted to life-threatening infections due to severe adverse effects and
drug-interactions. Local use of KTZ loaded nanocarrier system can address its toxicity, poor
solubility, photodegradation, permeation and bioavailability issues. Solid lipid nanoparticles …